BACKGROUND: Biological sex influences cigarette smoking behavior. More men than women smoke, but women have a harder time quitting. Sex differences in smoking cue (SC) reactivity may underlie such behavioral differences. However, the influence of sex on brain reactivity to SCs has yielded inconsistent findings suggesting the need for continued study. Here, we investigated the effect of sex on SC reactivity across two sites using different imaging modalities and SC stimulus types. METHODS: Pseudo-continuous arterial spin-labeled (pCASL) perfusion functional magnetic resonance imaging (fMRI) was used to assess brain responses to SC versus non-SC videos in 40 smokers (23 females) at the University of Pennsylvania. BOLD fMRI was used to assess brain responses to SC versus non-SC still images in 32 smokers (18 females) at McLean Hospital. Brain reactivity to SCs was compared between men and women and was correlated with SC-induced craving. RESULTS: In both cohorts, males showed higher SC versus non-SC reactivity compared to females in reward-related brain regions (i.e., ventral striatum/ventral pallidum, ventral medial prefrontal cortex). Brain activation during SC versus non-SC exposure correlated positively with SC-induced subjective craving in males, but not females. CONCLUSIONS: The current work provides much needed replication and validation of sex differences in SC-reactivity. These findings also add to a body of literature showing that men have greater reward-related brain activation to drug cues across drug classes. Such sex differences confirm the need to consider sex not only when evaluating SC-reactivity but when examining nicotine dependence etiology and treatment.
BACKGROUND: Biological sex influences cigarette smoking behavior. More men than women smoke, but women have a harder time quitting. Sex differences in smoking cue (SC) reactivity may underlie such behavioral differences. However, the influence of sex on brain reactivity to SCs has yielded inconsistent findings suggesting the need for continued study. Here, we investigated the effect of sex on SC reactivity across two sites using different imaging modalities and SC stimulus types. METHODS: Pseudo-continuous arterial spin-labeled (pCASL) perfusion functional magnetic resonance imaging (fMRI) was used to assess brain responses to SC versus non-SC videos in 40 smokers (23 females) at the University of Pennsylvania. BOLD fMRI was used to assess brain responses to SC versus non-SC still images in 32 smokers (18 females) at McLean Hospital. Brain reactivity to SCs was compared between men and women and was correlated with SC-induced craving. RESULTS: In both cohorts, males showed higher SC versus non-SC reactivity compared to females in reward-related brain regions (i.e., ventral striatum/ventral pallidum, ventral medial prefrontal cortex). Brain activation during SC versus non-SC exposure correlated positively with SC-induced subjective craving in males, but not females. CONCLUSIONS: The current work provides much needed replication and validation of sex differences in SC-reactivity. These findings also add to a body of literature showing that men have greater reward-related brain activation to drug cues across drug classes. Such sex differences confirm the need to consider sex not only when evaluating SC-reactivity but when examining nicotine dependence etiology and treatment.
Authors: Nadia Chaudhri; Anthony R Caggiula; Eric C Donny; Sheri Booth; Maysa A Gharib; Laure A Craven; Shannon S Allen; Alan F Sved; Kenneth A Perkins Journal: Psychopharmacology (Berl) Date: 2005-01-29 Impact factor: 4.530
Authors: Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews Journal: Neuroimage Date: 2004 Impact factor: 6.556
Authors: Teresa R Franklin; Ze Wang; Jiongjiong Wang; Nathan Sciortino; Derek Harper; Yin Li; Ron Ehrman; Kyle Kampman; Charles P O'Brien; John A Detre; Anna Rose Childress Journal: Neuropsychopharmacology Date: 2007-03-21 Impact factor: 7.853
Authors: Amy C Janes; Jordan W Smoller; Sean P David; Blaise Deb Frederick; Stephen Haddad; Aditi Basu; Maurizio Fava; A Eden Evins; Marc J Kaufman Journal: Drug Alcohol Depend Date: 2011-07-20 Impact factor: 4.492
Authors: Amy C Janes; Nathan L Krantz; Lisa D Nickerson; Blaise B Frederick; Scott E Lukas Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2019-09-23
Authors: A C Janes; J M Gilman; B B Frederick; M Radoman; G Pachas; M Fava; A E Evins Journal: Drug Alcohol Depend Date: 2017-11-21 Impact factor: 4.492
Authors: R Kathryn McHugh; Amy C Janes; Margaret L Griffin; Nadine Taghian; Shelly F Greenfield; Roger D Weiss Journal: Subst Use Misuse Date: 2020-02-10 Impact factor: 2.164
Authors: Elena Molokotos; Alyssa L Peechatka; Kainan S Wang; Diego A Pizzagalli; Amy C Janes Journal: Drug Alcohol Depend Date: 2020-02-29 Impact factor: 4.492
Authors: Landhing M Moran; William J Kowalczyk; Karran A Phillips; Massoud Vahabzadeh; Jia-Ling Lin; Mustapha Mezghanni; David H Epstein; Kenzie L Preston Journal: Am J Drug Alcohol Abuse Date: 2018-04-11 Impact factor: 3.829
Authors: Teresa R Franklin; Kanchana Jagannathan; Nathaniel H Spilka; Heather Keyser; Hengy Rao; Alice V Ely; Amy C Janes; Reagan R Wetherill Journal: Drug Alcohol Depend Date: 2021-02-13 Impact factor: 4.492
Authors: Dara G Ghahremani; Jean-Baptiste Pochon; Maylen Perez Diaz; Rachel F Tyndale; Andy C Dean; Edythe D London Journal: Neuropsychopharmacology Date: 2021-05-25 Impact factor: 7.853